Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Biosensors & Bioelectronics|July 15, 2011
Nanoparticle-based electrochemiluminescence immunosensor with enhanced sensitivity for cardiac troponin I using N-(aminobutyl)-N-(ethylisoluminol)-functionalized gold nanoparticles as labelsWen Shen, Dayong Tian, Hua Cui, et al.The Analyst|February 5, 2013
Label-free electrochemiluminescence immunosensor for cardiac troponin I using luminol functionalized gold nanoparticles as a sensing platformFang Li, Yuqi Yu, Hua Cui, et al.ACS Applied Materials & Interfaces|March 12, 2021
Reversible Rapid Hydrogen Doping of WO3 in Non-Acid SolutionZhiping Bian, Jiangtao Zhao, Heng Cao, et al.Journal of Nanoscience and Nanotechnology|January 25, 2006
Development of a low density colorimetric protein array for cardiac troponin I detectionHuishi Guo, Di Yang, Chunrong Gu, et al.ACS Applied Materials & Interfaces|March 25, 2015
Sensitive immunosensor for N-terminal pro-brain natriuretic peptide based on N-(aminobutyl)-N-(ethylisoluminol)-functionalized gold nanodots/multiwalled carbon nanotube electrochemiluminescence nanointerfaceHongli Zhang, Zhili Han, Xu Wang, et al.Analytical Chemistry|September 19, 2019
Chemiluminescence Immunoassays for Simultaneous Detection of Three Heart Disease Biomarkers Using Magnetic Carbon Composites and Three-Dimensional Microfluidic Paper-Based DeviceRui Yang, Fang Li, Wencan Zhang, et al.Colloids and Surfaces. B, Biointerfaces|January 26, 2007
Preparation of anti-human cardiac troponin I immunomagnetic nanoparticles and biological activity assaysSong Zhang, Zhiping Bian, Chunrong Gu, et al.Analytical Chemistry|September 23, 2020
Potential-Resolved Differential Electrochemiluminescence Immunosensor for Cardiac Troponin I Based on MOF-5-Wrapped CdS Quantum Dot NanoluminophoresDexin Du, Jiangnan Shu, Mingquan Guo, et al.International Journal of Molecular Medicine|September 24, 2015
Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cellsYao Lu, Su Li, Hengfang Wu, et al.Clinical and Experimental Pharmacology & Physiology|April 23, 2021
Atorvastatin reverses high cholesterol-induced cardiac remodelling and regulates mitochondrial quality-control in a cholesterol-independent manner: An experimental studyPeng Zheng, Yanzi Ding, Feiyan Lu, et al.Pageof 3